Norovirus Infection in Children with Acute Lymphoblastic Leukemia
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Norovirus infection in children on treatment for acute lymphoblastic leukemia can lead to severe morbidity due to chronic viral shedding, malabsorption, failure to thrive, and interruption of chemotherapy. We had four children with norovirus diarrhoea in eight years period in our pediatric oncology unit. Three children under two years of age had chronic noroviral shedding and persistent diarrhoea, probably due to poor adaptive immune responses. Two of those children didn’t respond to nitazoxanide and succumbed to the illness. The third patient who received nitazoxanide and favipiravir, is currently well on chemotherapy.
Abstract
Norovirus infection in children on treatment for acute lymphoblastic leukemia can lead to severe morbidity due to chronic viral shedding, malabsorption, failure to thrive, and interruption of chemotherapy. We had four children with norovirus diarrhoea in eight years period in our pediatric oncology unit. Three children under two years of age had chronic noroviral shedding and persistent diarrhoea, probably due to poor adaptive immune responses. Two of those children didn’t respond to nitazoxanide and succumbed to the illness. The third patient who received nitazoxanide and favipiravir, is currently well on chemotherapy.
참고문헌 (14)
- Mhaissen MN, "Epidemiology of diarrheal illness in pediatric oncology patients", J Pediatric Infect Dis Soc, 6, pp.275~280 (2017)
- Ghosh N, "Viral associated diarrhea in immunocompromised and cancer patients at a large comprehensive cancer center : a 10-year retrospective study", Infect Dis(Lond), 49, pp.113~119 (2017)
- Shah MP, "Norovirus illnesses in children and adolescents", Infect Dis Clin North Am, 32, pp.103~118 (2018)
- Roddie C, "Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis : a previously unrecognized cause of morbidity", Clin Infect Dis, 49, pp.1061~1068 (2009)
- Brown LK, "A comprehensive characterization of chronic norovirus infection in immunodeficient hosts", J Allergy Clin Immunol, 144, pp.1450~1453 (2019)
- Simon AK, "Evolution of the immune system in humans from infancy to old age", Proc Biol Sci, 282, pp.20143085~ (2015)
- Pieters R, "Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol : results from an international phase III randomized study", J Clin Oncol, 37, pp.2246~2256 (2019)
- Vora A, "Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease(UKALL 2003) : a randomised controlled trial", Lancet Oncol, 14, pp.199~209 (2013)
- Simon A, "Norovirus outbreak in a pediatric oncology unit", Scand J Gastroenterol, 41, pp.693~699 (2006)
- Hassan E, "Norovirus encounters in the gut : multifaceted interactions and disease outcomes", Mucosal Immunol, 12, pp.1259~1267 (2019)
- Ludwig A, "Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus", J Med Virol, 80, pp.1461~1467 (2008)
- Kondapi DS, "Norovirus in cancer patients : a review", Open Forum Infect Dis, 8, pp.ofab126~ (2021)
- Ruis C, "Mutagenesis in norovirus in response to favipiravir treatment", N Engl J Med, 379, pp.2173~2176 (2018)
- Furuta Y, "Favipiravir(T-705), a broad spectrum inhibitor of viral RNA polymerase", Proc Jpn Acad, Ser B, Phys Biol Sci, 93, pp.449~463 (2017)